The Pain Review Course 2017 - Post Nerve Injury Pain

The Pain Review Course 2017 - Post Nerve Injury Pain

Release Date: 02/21/2022

Expiration Date: 12/31/2024

This educational activity has been planned and implemented by:

Intended Audience

This activity is intended for pain medicine specialists preparing for certification or re-certification in Pain Medicine, other allied health care professionals interested in expanding their knowledge and improving their practice in pain medicine, and others on the Healthcare Team with an interest in pain management.

Learning Objectives

Upon completion of this activity, the participant should be able to:

• Response of afferent/DRG and spinal cord to physical and chemical injury of peripheral nerve.
• Review mechanisms whereby peripheral nerve injury leads to on going pain sensations (e.g. dysesthesias).
• Review changes in spinal processing that underlie development of pain secondary to low threshold mechanical stimulation. (e.g. tactile allodynia).

Statement of Need

Dannemiller is an organization dedicated to the presentation of postgraduate education courses for the purpose of updating and reviewing of all areas in the specialties of anesthesia and pain management. For more than a decade, Dannemiller has sponsored numerous CME activities in the area of pain management. As a result of this experience, Dannemiller has had the opportunity to recruit experts from all of the disciplines involved in pain management Through evaluation of the Outcomes Studies Reports of these previously sponsored activities, which incorporated feedback from both attendees and experts, Dannemiller has carefully planned this CME activity to provide information that will enhance the attendee's ability to recognize, evaluate, and treat the patient with chronic pain.

Accreditation Statement(s)

THIS ACTIVITY HAS EXPIRED FOR AANA ONLY.

In support of improving patient care, this activity has been planned and implemented by Dannemiller. Dannemiller is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurse Anesthetists

The Pain Review Course 2017 - Post Nerve Injury Pain has been prior approved by the American Association of Nurse Anesthesiology for 1.25 Class A CE credits; AANA Code Number 1041654; Expiration Date 12/31/2023.

Physician Assistants

Dannemiller has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 1.25 AAPA Category 1 CME credits. Approval is valid until 12/31/2024. PAs should only claim credit commensurate with the extent of their participation.

Nurses

Dannemiller designates this educational activity for 1.25 contact hours, which includes 0.00 pharmacotherapeutic hours.

Physicians

Dannemiller designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

THIS ACTIVITY HAS EXPIRED FOR AANA ONLY.

Method of Participation

This activity should take approximately 1.25 hour(s) to complete. Participants should first read the objectives and other introductory CME/CE information and then proceed to the educational activity. To receive credit for this activity, participants must complete the post-test with a passing score of 80% and then complete the evaluation. Credit is provided through 12/31/2024. No credit will be given after this date. There is $12.50 fee to participate in this activity.

In the event you have questions about this activity or are unable to retrieve the certificate, please email cme@dannemiller.com and a certificate will be emailed within 2 weeks.

System Requirements

• Computer, tablet, or smartphone with internet access
• Web browser (Chrome, Firefox, Edge) with JavaScript enabled
• HTML5 compatible browser or Adobe Flash Player

Browser
Please ensure that you are running the latest version of one of these web browsers:

• Google Chrome
• Mozilla Firefox
• Microsoft Edge
• Safari
• Opera

Video
Viewers must have a minimum stable download speed of 500 kbps to play low-resolution SD 240p video from Dannemiller. For a more enjoyable viewing experience and to play high-definition video, we recommend accessing Dannemiller using a 5 Mbps or faster internet connection. Whenever possible, hardwired ethernet connections are preferred over wireless (Wi-Fi or cellular).

Audio
We recommend a steady internet connection of 1.5 to 2 Mbps for audio streaming.

Faculty

• Tony L. Yaksh, PhD

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence, Dannemiller requires that any person who is in a position to control the content of a CME activity must disclose all financial relationships they have with an ineligible company within the last 24 months. If an individual refuses to disclose, they are disqualified from participating within the activity. The disclosures are evaluated for relevance. All relevant financial relationships have been mitigated. The resulting certified activity was found to provide educational content that is current and evidence-based to protect learners from commercial bias and marketing. 

The following faculty stated they have no financial relationships with ineligible companies:

The following faculty stated they have financial relationships with ineligible companies: Tony L. Yaksh, PhD - Investigator for Medtronics Coda, ASANA, Sintetica; Advisory/Medical Board - Navega, OpsinBio; Stockholder - Navega 

Dr. Bernard Abrams, the Content Reviewer; Kim DuQue-Urdialez and Amber Johnston, Dannemiller Project Managers have no financial relationships with ineligible companies.

Off-label Statement

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Disclaimer

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Dannemiller, or . This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject.

• Computer, tablet, or smartphone with internet access
• Web browser (Chrome, Firefox, Edge) with JavaScript enabled
• HTML5 compatible browser or Adobe Flash Player

Browser
Please ensure that you are running the latest version of one of these web browsers:

• Google Chrome
• Mozilla Firefox
• Microsoft Edge
• Safari
• Opera

Video
Viewers must have a minimum stable download speed of 500 kbps to play low-resolution SD 240p video from Dannemiller. For a more enjoyable viewing experience and to play high-definition video, we recommend accessing Dannemiller using a 5 Mbps or faster internet connection. Whenever possible, hardwired ethernet connections are preferred over wireless (Wi-Fi or cellular).

Audio
We recommend a steady internet connection of 1.5 to 2 Mbps for audio streaming.